$0.96
-0.0047 (-0.487%)
At Close: Jun 22, 2026
3 Canadian Marijuana Stocks To Watch This March
07:00am, Tuesday, 01'st Mar 2022
3 Marijuana Stocks To Watch March 1st The post 3 Canadian Marijuana Stocks To Watch This March appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
OrganiGram Holdings Inc. (NASDAQ: OGI) : Investors Should Not Dump OGI Stock In 2022
08:00pm, Monday, 28'th Feb 2022 Marketing Sentinel
In the latest trading session, 2.13 million OrganiGram Holdings Inc. (NASDAQ:OGI) shares changed hands as the company’s beta touched 1.13. With the company’s most recent per share price at $1.50 changing hands around $0.01 or 1.01% at last look, the market valuation stands at $594.20M. OGI’s current price is a discount, trading about -212.0% off … OrganiGram Holdings Inc. (NASDAQ: OGI) : Investors Should Not Dump OGI Stock In 2022 Read More »
7 Top Marijuana Penny Stocks To Buy Before Optimism Ignites Again
03:10pm, Friday, 25'th Feb 2022
Marijuana penny stocks may rally violently if optimism returns to the cannabis industry. Think of a 1,687% gain under similar conditions.
Organigram Holdings Inc. Announces Election of Directors - Technical420
12:24pm, Friday, 25'th Feb 2022 Technical420
Technical420 is dedicated to educating investors about the risk and rewards of investing in the cannabis industry. We highlight companies that have the most growth potential by utilizing our proprietary analytics platform.
Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check Verified
09:38pm, Thursday, 24'th Feb 2022 Benzinga
Former Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc . (CSE: MMEN) (OTCQX: MMNFF ) has appointed Ana Bowman as a chief financial officer, effective February 22. Bowman will succeed outgoing interim CFO Reece Fulgham, who will be returning to consulting firm SierraConstellation Partners. Bowman brings years of cannabis industry expertise, having served as vice president of financial reporting and FP&A of Tilray Brands (NASDAQ: TLRY ) (TSX:TLRY). Prior to joining Tilray, Bowman served as corporate controller of several publicly-traded U.S. registrants, following an exit from the world of big four public accounting. "We are excited to have Ana join as our permanent CFO — bringing with her significant financial expertise from her time at Tilray and large public accounting and auditing firms, including Ernst & Young and Deloitte," Michael Serruya, MedMen''s chairman and CEO said. "We also want to thank Reece for stepping in as our interim CFO and wish him well in his future endeavors." Organigram Holdings Elects Directors Organigram Holdings Inc. (TSX: …
3 Marijuana Stocks For Your February Watchlist
07:00am, Thursday, 17'th Feb 2022
Are You Buying The Best Marijuana Stocks? 3 To Watch In 2022 The post 3 Marijuana Stocks For Your February Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budd
Why Marijuana Stocks Like Aurora Cannabis Rose So Much Today
11:55pm, Tuesday, 15'th Feb 2022 The Motley Fool
There's a promising development in one U.S. state.
Why Marijuana Stocks Like Aurora Cannabis Rose So Much Today
06:55pm, Tuesday, 15'th Feb 2022
There's a promising development in one U.S. state.
Why Canopy Growth, Hexo, and OrganiGram Are Slumping Today
09:20pm, Monday, 14'th Feb 2022 The Motley Fool
Canadian marijuana stocks are reversing course Monday after last week's industrywide surge higher.
Why Canopy Growth, Hexo, and OrganiGram Are Slumping Today
09:20pm, Monday, 14'th Feb 2022 The Motley Fool
Canadian marijuana stocks are reversing course Monday after last week''s industrywide surge higher.
Why Canopy Growth, Hexo, and OrganiGram Are Slumping Today
04:20pm, Monday, 14'th Feb 2022
Canadian marijuana stocks are reversing course Monday after last week's industrywide surge higher.
The Week In Cannabis: Schumer's Bill, The Super Bowl, Leafly, Canopy Growth, Tilray, Hexo, Sundial And More
06:44pm, Friday, 11'th Feb 2022 Benzinga
Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022.
Contents
Schumer Urges Senators To Help Finalize Marijuana Legalization Bill
No
Organigram Reports Highest Quarterly Net Revenue Ever In Q1, Remains Among Top Canadian Cannabis LPs
02:51pm, Friday, 11'th Feb 2022 Benzinga
Cannabis company Organigram Holdings Inc. (NASDAQ: OGI ) (TSX: OGI) announced its results for the first quarter ended November 30, 2021. “Our r ecord-breaking results in the first quarter of fiscal 2022 are a testament to our successful strategy to create innovative, high-quality products that align with the evolving preferences of the various segments of cannabis consumers,” Beena Goldenberg, the company’s CEO, said. “Our positive outlook for 2022 is further bolstered by the addition of Laurentian’s premium products to our portfolio, with an increased presence in Quebec and the resumption of international sales, which will continue through the year.” Q1 2022 Financial Highlights Compared to the prior year, net revenue increased 57% to $30.4 million, from $19.3 million in the first quarter of fiscal 2021, representing a highest quarterly net revenue in the history of the company. Cost of sales increased by 20% to $27.9 million year-over-year, primarily … Full story available on Benzinga.
Catch Up On the Busiest Week For Cannabis Stocks of 2022
01:42pm, Friday, 11'th Feb 2022
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we mak
Benzinga Interview: Organigram CEO Beena Goldenberg Discusses Company Performance And Canadian Cannabis Market
01:36pm, Friday, 11'th Feb 2022 Benzinga
OrganiGram Holdings Inc (NASDAQ: OGI) (TSE: OGI) CEO Beena Goldenberg recently spoke with Benzinga to discuss the company's ongoing growth and Q2 success. Crediting the team for persevering during the
Sign In
Buy OGI